Studying of pharmacological activity of medical product «Energodarin»

Article is devoted to comparative pharmacological studying of action of the developed medical product (MP) «Energodarin» on the one hand, and results of monotherapy by levzei liquid extract, potassium orotat, calcium glycerophosphatum and «Anastan» (BAA, containing 20-гидроксиэкдистеронов) - with another. It is estab-lished, that new combined MP increases physical working capacity and its efficiency in 3 times in comparison with monotherapy by components which are a part of «Energodarin». MP «Energodarin» possesses stress-protective activity and shows anabolic action. As a result of the lead hematological and biochemical researches it is established, that long-term reception of MP does not cause changes in clinical and biological parameters of a blood.